4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
BioXcel Therapeutics, Inc. (BTAI) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in New Haven, United States with about 29 employees. Its market capitalization is roughly $32 million. In the fiscal year ended 2025-12-31, BTAI reported $1M in revenue and ($70M) in net income.
BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.
Interactive charts & full statements → Open the BTAI valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $1M | $2M | $1M | $0M |
| Gross Profit | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($50M) | ($65M) | ($168M) | ($160M) |
| Net Income | ($70M) | ($60M) | ($179M) | ($166M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | ($0M) | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($10M) | ($10M) | ($14M) | ($16M) | ($10M) | — |
| Net Income | ($13M) | ($12M) | ($31M) | ($19M) | ($7M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $45M | $38M | $74M | $206M | — |
| Total Liabilities | $140M | $131M | $130M | $129M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BTAI viewer.
About TickerBase · Data methodology & sources